Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · IEX Real-Time Price · USD
7.52
-0.84 (-10.05%)
At close: Jul 2, 2024, 4:00 PM
7.50
-0.02 (-0.27%)
After-hours: Jul 2, 2024, 7:03 PM EDT

Atara Biotherapeutics Statistics

Total Valuation

ATRA has a market cap or net worth of $36.88 million. The enterprise value is $68.27 million.

Market Cap 36.88M
Enterprise Value 68.27M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

ATRA has 4.90 million shares outstanding. The number of shares has increased by 35.22% in one year.

Shares Outstanding 4.90M
Shares Change (YoY) +35.22%
Shares Change (QoQ) +29.98%
Owned by Insiders (%) 9.13%
Owned by Institutions (%) 69.54%
Float 3.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.06
Forward PS 0.40
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.97
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.59

Current Ratio 0.59
Quick Ratio 0.46
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -44.69

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -121.70%
Return on Capital (ROIC) n/a
Revenue Per Employee $200,601
Profits Per Employee -$1.35M
Employee Count 173
Asset Turnover 0.18
Inventory Turnover 0.99

Taxes

In the past 12 months, ATRA has paid $17,000 in taxes.

Income Tax 17,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.08% in the last 52 weeks. The beta is 0.53, so ATRA's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change -81.08%
50-Day Moving Average 13.87
200-Day Moving Average 19.79
Relative Strength Index (RSI) 27.19
Average Volume (20 Days) 132,995

Short Selling Information

Short Interest 10.78M
Short Previous Month 11.27M
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 9.58

Income Statement

In the last 12 months, ATRA had revenue of $34.70 million and -$233.11 million in losses. Loss per share was -$53.25.

Revenue 34.70M
Gross Profit 24.05M
Operating Income -232.24M
Pretax Income -233.09M
Net Income -233.11M
EBITDA -211.11M
EBIT -227.99M
Loss Per Share -$53.25
Full Income Statement

Balance Sheet

The company has $46.39 million in cash and $77.77 million in debt, giving a net cash position of -$31.39 million or -$6.40 per share.

Cash & Cash Equivalents 46.39M
Total Debt 77.77M
Net Cash -31.39M
Net Cash Per Share -$6.40
Equity (Book Value) -98.31M
Book Value Per Share -20.05
Working Capital -74.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$184.16 million and capital expenditures -$926,000, giving a free cash flow of -$185.09 million.

Operating Cash Flow -184.16M
Capital Expenditures -926,000
Free Cash Flow -185.09M
FCF Per Share -$32.91
Full Cash Flow Statement

Margins

Gross margin is 69.30%, with operating and profit margins of -669.19% and -671.70%.

Gross Margin 69.30%
Operating Margin -669.19%
Pretax Margin -671.65%
Profit Margin -671.70%
EBITDA Margin -608.32%
EBIT Margin -656.95%
FCF Margin -533.33%

Dividends & Yields

ATRA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -35.22%
Shareholder Yield -35.22%
Earnings Yield -632.07%
FCF Yield -501.86%

Analyst Forecast

The average price target for ATRA is $6.04, which is -19.68% lower than the current price. The consensus rating is "Hold".

Price Target $6.04
Price Target Difference -19.68%
Analyst Consensus Hold
Analyst Count 7
Revenue Growth Forecast (5Y) 77.96%
EPS Growth Forecast (5Y) -70.21%
Stock Forecasts

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date Jun 20, 2024
Split Type Reverse
Split Ratio 1:25

Scores

ATRA has an Altman Z-Score of -21.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -21.75
Piotroski F-Score 3